Today: 28 April 2026
Applied Materials Stock Falls as U.S. Curbs Put China Chip-Tool Sales Back in Focus

Applied Materials Stock Falls as U.S. Curbs Put China Chip-Tool Sales Back in Focus

SANTA CLARA, California, April 28, 2026, 11:03 PDT

  • Applied Materials’ ties to China are once again in the spotlight for AMAT stock, thanks to U.S. export moves.
  • Shares dropped roughly 5.5% on Tuesday. Lam Research and KLA shares also ended the day in the red.
  • Applied Materials drew 30% of its revenue from China in the most recent quarter.

Shares of Applied Materials dropped Tuesday, following a Reuters report that the U.S. Commerce Department last week ordered certain chip equipment makers to stop sending some tools to Hua Hong, China’s No. 2 chip producer. Lam Research, Applied Materials, and KLA were thought to be among the firms that got letters, Reuters said, citing sources familiar with the situation.

This matters now because Applied’s China business remains sizable, despite multiple waves of U.S. export restrictions. AMAT shares dropped $22.07 to $382.79. Lam Research and KLA each slid about 3.3%, weighing on a sector that’s been boosted lately by AI chipmaking demand.

U.S. officials are moving to block shipments of certain tools and materials headed to Hua Hong facilities, targeting what they say could be used for advanced chip production, according to Reuters. Hua Hong’s Huali Microelectronics unit, Reuters added, has been working on a 7-nanometer process at its Shanghai site. That 7-nanometer label signals a high-end chip technology—smaller numbers translate to greater chip density.

Reuters said the Commerce Department wouldn’t comment. Hua Hong, Lam Research, Applied Materials and KLA also didn’t respond right away to requests for comment.

Filings from Applied lay out the numbers that caught investors’ attention. China brought in $2.095 billion during the quarter ending Jan. 25, about 30% of overall revenue—down from $2.243 billion, or 31%, in the same stretch last year. Taiwan contributed 25%, Korea 21%, according to the filing.

The company’s core business is wafer-fabrication gear—equipment that transforms raw silicon wafers into chips—plus related services and software. For the quarter, foundry, logic, and other chipmakers delivered 62% of Semiconductor Systems revenue, while DRAM, the memory staple for computing, contributed 34%.

The selloff is hitting chip-equipment makers even as Wall Street remains bullish on the sector. On Tuesday, Bank of America listed Applied, Lam, and MKS Instruments as key players for wafer-fab equipment growth. Still, it warned about potential downside for Applied due to U.S. government-related risks.

Applied management keeps flagging AI-driven demand to investors. Back in February, Chief Executive Gary Dickerson described semiconductors as “the heart of the AI technology stack” and said Applied was on track for over 20% growth in its semiconductor equipment business this calendar year. Applied Materials

There’s a catch: export controls could start to hit before AI-driven demand has a chance to make up the slack. In its most recent quarterly filing, Applied cautioned that getting China-related export licenses isn’t easy. If it can’t lock them down, the company could lose out on sales, get edged out by Chinese or other foreign competitors, and see financial results take a hit.

Export-control questions continue to hang over the company. Applied disclosed a Feb. 11 settlement with the Commerce Department’s Bureau of Industry and Security, tied to shipments to Chinese customers and export compliance lapses. The company will pay $253 million and has committed to internal audits.

Up next: earnings. Applied is set to release its fiscal second-quarter numbers on May 14. Investors will be watching to see if management says the Hua Hong move affects the company’s outlook for China or its AI-driven growth strategy.

Stock Market Today

  • Celestica Stock Falls 13% Amid Trading Volume Decline and Analyst Upgrades
    April 28, 2026, 3:06 PM EDT. Celestica Inc. (TSE:CLS) shares dropped 13% mid-day Tuesday, falling from a previous close of C$576.75 to as low as C$480.00 before settling near C$501.93. Trading volume declined 45%, with approximately 294,198 shares exchanging hands against the average 536,067. Despite the stock decline, six analysts rate it a Strong Buy, with a consensus target price of C$305.00. The company recently reported quarterly earnings of C$3.00 per share and revenue of C$5.63 billion. Celestica, specializing in supply chain solutions, maintains a market cap of C$56.30 billion, a price-to-earnings ratio of 68.39, and a debt-to-equity ratio of 35.04. Strong analyst upgrades contrast with the stock's sharp drop.

Latest article

Baiya International’s $1 Million BNB Bet Sends BIYA Stock Sharply Higher

Baiya International’s $1 Million BNB Bet Sends BIYA Stock Sharply Higher

28 April 2026
Baiya International Group said Binance Coin (BNB) won 89.2% of a public vote and will be the first core digital asset in its new “Cryptocurrency Ark Plan.” BIYA shares surged 82% to $1.42 on Nasdaq, with trading volume near 184 million. The company plans an initial $1 million BNB purchase and will use trading gains for share buybacks. Recent filings indicate possible equity dilution as Baiya moves into crypto trading.
Vistance Networks Stock Was Cut in Half. The $10 Payout Explains Why

Vistance Networks Stock Was Cut in Half. The $10 Payout Explains Why

28 April 2026
Vistance Networks shares fell nearly 49% Tuesday after trading ex-dividend for a $10 special cash payout funded by proceeds from its January sale of the Connectivity and Cable Solutions business to Amphenol. The stock was down 48.7% at $10.01 in afternoon trading, with volume more than double recent averages. Vistance will report first-quarter results before the market opens April 30.
UnitedHealth Stock Jumps as Centene Results Put Insurer Turnaround Back in Play

UnitedHealth Stock Jumps as Centene Results Put Insurer Turnaround Back in Play

28 April 2026
UnitedHealth Group shares rose about 4% Tuesday after Centene raised its profit forecast, fueling optimism that medical-cost pressures may be easing for large insurers. UnitedHealth last week lifted its 2026 profit outlook and reported a first-quarter medical care ratio of 83.9%. Centene’s medical loss ratio came in below analyst estimates. UnitedHealth’s Optum unit continues to face cost and contract challenges.
Navitas Stock Slides 17% as AI Power-Chip Rally Runs Into Earnings Test
Previous Story

Navitas Stock Slides 17% as AI Power-Chip Rally Runs Into Earnings Test

UnitedHealth Stock Jumps as Centene Results Put Insurer Turnaround Back in Play
Next Story

UnitedHealth Stock Jumps as Centene Results Put Insurer Turnaround Back in Play

Go toTop